| Application no. and date | 20715020.2 (espacenet) (Federated) (European Patent Register), 20200325 | | Patent/reg. no. and date | DK/EP 3947375, 20240403 | | Publication date | 20220209 | | Priority no. and date | EP 19165664, 20190327 | | EP pub. no. and date |
EP 3947375 20220209 | | Effective date | | | Applicant/owner | Merck Patent GmbH, Frankfurter Strasse 250
64293 Darmstadt, DE | | Applicant ref. no. | P84532DK01 | | Inventor | GRAEDLER, Ulrich, Oberer Klingenberg 2
69469 Weinheim, DE,
FUCHSS, Thomas, Jahnstrasse 12
64625 Bensheim-Auerbach, DE,
KUBAS, Holger, Platanenring 98
61352 Bad Homburg, DE,
BECKER, Axel, Am Grundweg 21
64342 Seeheim-Jugenheim, DE | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup | | Opponent | | | IPC Class | A61K 31/4375 (2006.01) , A61P 35/00 (2006.01) , C07D 471/04 (2006.01) | | Title | IMIDAZOLONYLQUINOLINFORBINDELSER OG TERAPEUTISKE ANVENDELSER DERAF | | Int. application no. | EP2020058425 | | Int. publication no. | WO2020193660 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
